期刊文献+

多重荧光定量PCR对三种主要致病性曲霉菌的检测研究

Development of multiplex fluorescent quantitative PCR for detection of common pathegenic aspergillus species
原文传递
导出
摘要 目的建立一种能同时鉴定烟曲霉、黄曲霉和黑曲霉菌的多重荧光定量PCR诊断方法,并将之应用于侵袭性曲霉菌病的诊断研究。方法构建多重荧光定量PCR方法,对该方法进行实验评价,并将之应用于侵袭性曲霉菌病患者的痰标本检测,初步评价该方法的临床诊断效能。结果建立的多重荧光定量PCR方法,制定标准曲线,R^2。在0.989~0.999之间,斜率分别为-3.117、-3.583、-3.674;只与烟曲、黄曲、黑曲的DNA发生特异性反应,无非特异性扩增;最低检测浓度为1×10^2孢子/ml;重复性检测试验,获得Ct值标准差为0.12~0.20,变异系数为0.37%~0.80%;对分离自26例侵袭性曲霉菌病患者的56份深部痰标本进行检测,敏感率为85.7%(48/56),特异性为92.0%(46/50),阳性预测值为92.3%(48/52),阴性预测值为85.2%(46/54)。结论研究建立的多重荧光定量PCR方法检测侵袭性曲霉菌病患者的深部痰标本有较高的敏感性、特异性和阴、阳性预测值,且快速、简便,将有助于侵袭性曲霉菌病的早期准确诊断。 Objective To establish a method for the early diagnosis of invasive aspergillosis (IA) using multiplex fluorescent quantitative polymerase chain reaction (FQ-PCR), which can identify different species, including A. fumigatus, A. flavus and A. niger. Methods To establish a method of multiplex FQ-PCR and make a experimental evaluation. To deteete the patients' sputum samples who with IA using thetechnique that had been established, and the sensitivity, specificity, positive and negative predictive value of the technique were estimated with all the collected samples. Results The R2 of standard curve of each species for multiplex FQ-PCR was 0. 989 - 0. 999 , the slope were -3. 117,-3. 583,-3. 674, respectively. The present multiplex FQ-PCR system was exclusively positive for DNA extracted from the three species of aspergillosis, but not the other fungi, bacterium and human PBMC. The lowest limit of the system for the four aspergillosis was 1 × 10^2 spores/ml. The standard error of Ct value was 0.12-0.20 and coefficient of variation was 0. 37%-0. 80% , which demonstrated a high repeatability. Sensitivity, specificity, positive and negative predictive value of the the multiplex FQ-PCR were 85.7% (48/56), 92.0%(46/50), 92.3% (48/52) and 85.2% (46/54) respectively. Conclusions The multiplex FQ-PCR established for the detection of IA has good sensitivity, specificity and predictive value when using the sputum sample from IA-infected patients. This proved that it could greatly benefit the early diagnosis for IA infection in immunoeompromised patients and used as a routine diagnosis method in the future.
出处 《国际呼吸杂志》 2012年第2期99-102,共4页 International Journal of Respiration
基金 基金项目:广东省科技计划项目(2010B031600148) 广州市科技计划项目(2010J-E171)
关键词 曲霉菌 侵袭性曲霉菌病 实时荧光定量聚合酶链反应 诊断 Aspergillosis Invasive fungal disease~ Real-time polymerase chain reaction Diagnosis
  • 相关文献

参考文献9

  • 1Denning DW. Invasive aspergillosis. Clin Infect Dis, 1998,26 781-803.
  • 2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:864
  • 3FaberJ, Moritz N, Henninger N, et al. Rapid detection of common pathogenic Aspergillus species by a novel real-time PCR approach. Mycoses, 2009,52 : 228-233.
  • 4Botterel F, Farrugia C, Ichai P,et al. Real-time PCR on the first galactornannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl Infect Dis, 2008,10 : 333-338.
  • 5Espy MJ, Uhl JR, Sloan LM,et al. Real-time PCR in clinical microbiology:applications for routine laboratory testing. Clin Microbiol Rev, 2006,19 : 165-256.
  • 6Ferrer C, Colom F, Fras6s S, et al. Detection and identification of funga] pathogens by PCR and by ITS2 and 5.8 S ribosomal DNA typing in ocular infections. J Clin Microbiol, 2001,39 : 2873-2879.
  • 7Fujita S, Lasker BA, Lott TJ, et al. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol, 1995,33 : 962-967.
  • 8Fredricks DN, Smith C, Meier A. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol,2005,43:5122-5128.
  • 9Mengoli C, Cruciani M, Barnes RA, et al. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis, 2009,9 : 89-96.

二级参考文献7

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
  • 3Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
  • 4Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
  • 5Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.
  • 6Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200.
  • 7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis,2000,30:710-718.

共引文献863

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部